Vienna-based probiotics company HSO Health Care is sold to Danish biotech firm Chr. Hansen by Alexander Schütz and Helmut Essl. Alexander Schütz was holding HSO through his family office, which is an active private equity investor in Austria.
HSO Health Care: Probiotics for Women
HSO was founded in 2007 by Helmut Essl. The company is doing research in the probiotics field. Probiotics are microorganisms that are claimed to provide health benefits. HSO’s main product is the patented Astarte products which are sold in several countries. In Switzerland, the product is called Biotics-fem and marketed by the Burgerstein – Antistress AG, in the United States the products are marketed by Jarrow and iHealth as Jarro-Dophilus, Azo or Culturelle probiotics. Now, Danish stock-listed biotech company Chr. Hansen is acquiring HSO and its patented Astarte product.
Alexander Schütz Vienna-based Single Family Office as private equity investor
Alexander Schütz’s family office was an investor in HSO. Schütz is the founder and CEO of the Austrian C-Quadrat Investment group with 8 billions of assets under management. Through his family office, Schütz invests in startups, private equity deals and real estate. Other investments include biotech company ATAI Life Sciences, ADC Therapeutics, Cyberfinancials GmbH or Cyan Digital Security.
You might like these family office articles
- Chinese “Mighty Divine” Family Office Acquires £94M Property In London
- Single Family Office from Hannover Invests In Gapless €5.5M Funding Round
- Danish Single Family Office Invests In Austrian Medtech Startup